A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
